Market Share of Myasthenia Gravis Therapeutics Industry
Majority of the myasthenia gravis therapeutics are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness and this has also helped the market grow.
Myasthenia Gravis Therapeutics Market Leaders
-
Alexion Pharmaceuticals Inc
-
Mitsubishi Tanabe Pharma
-
Astellas Pharma
-
Bausch Health
-
UCB S.A.
*Disclaimer: Major Players sorted in no particular order
